Status:
COMPLETED
123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT System
Lead Sponsor:
Timothy M. Bateman
Collaborating Sponsors:
GE Healthcare
Conditions:
Heart Failure
Cardiomyopathy
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to demonstrate correlation of the H/M ratio of AdreView when derived from a large field of view Anger SPECT system and from a small field of view high sensitivity (CZT) SP...
Eligibility Criteria
Inclusion
- New York Heart Association Class II or III Heart Failure
- Left ventricular ejection fraction less than or equal to 35%
Exclusion
- Uncompensated heart failure
- Recent hospitalization within 30 days of cardiac related indications
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01868841
Start Date
December 1 2013
End Date
October 1 2014
Last Update
January 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Imaging Technologies
Kansas City, Missouri, United States, 64111